Ebitda Изменить Дата
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
ANI Pharmaceuticals USD 71.6M 6.69M 2026-06
Ardelyx USD -29.77M 35.79M 2026-03
Aurora Cannabis CAD 3.7M 14.78M 2026-03
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Bristol-Myers Squibb USD 3.48B 1.6B 2026-09
Canopy Growth CAD -137M 134.13M 2026-03
Corcept Therapeutics USD -49M 53.2M 2026-03
Eli Lilly USD 9.46B 3.54B 2026-09
J&J USD 8.99B 721M 2026-06
Knight Therapeutics CAD 24.45M 3.46M 2025-12
Lexicon Pharmaceuticals USD -12.04M 15.95M 2025-09
Merck USD 1.42B 2.97B 2026-06
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Novartis USD 8.62B 2.14B 2026-09
Novartis USD 5.41B 431M 2026-03
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 48.67M 8.43M 2026-06
Pfizer USD 6.01B 18M 2026-06
Supernus Pharmaceuticals USD 55.6M 24M 2026-09
TG Therapeutics USD 26.9M 1.21M 2026-06